Increasingly acquisitive Charles River Laboratories has signed a new pact with the Milner Therapeutics Institute and Consortium that will see it become the…

Pittsburgh’s Velocity Fund Partners has picked up CRO IndiPharm for an undisclosed amount, renaming the Philadelphia firm InClinica.

inVentiv will cancel its planned IPO this summer after receiving a major investment from buyout firm Advent as it joins Thomas H. Lee Partners in having an…

Drilling deeper into its drug discovery platform, hybrid biotech-CRO Evotec has signed a deal with British charity Antibiotic Research UK to help older…

Germany’s Evotec has penned a new deal with a leading U.S. university that will see it gain access to one of the hottest tickets in drug development: CRISPR…

In a deal that adds heft to a list of leading biopharma clients, Cognizant has partnered with Biogen to provide its SmartTrials clinical trial data management…

Massachusetts-based CRO Veristat is looking to align itself with some of the world’s biggest CROs in the research services homeland of North Carolina.

CRO inVentiv Health has become the latest “preferred provider” to be chosen by Pfizer to help with its clinical operations to support the Big Pharma’s research…

San Diego- and China-based BioDuro, which merged with San Diego’s Formex late last year, announced at BIO this week its formal acquisition of Formex to form…

Partnering